Home The Word Brain My Amedeo FAQ Privacy About   


Chinese Coaching

Already know some Chinese? Stay on track with structured, one-on-one coaching to make steady, long-term progress. By Meng Wu and BSK.


  Irritable Bowel Syndrome

  Free Subscription


05.01.2026

1 Adv Exp Med Biol
3 Aliment Pharmacol Ther
1 Ann Parasitol
4 Best Pract Res Clin Gastroenterol
1 Biomed Res Int
1 BMC Gastroenterol
1 Clin Rheumatol
2 Cureus
1 Daru
1 Eur J Gastroenterol Hepatol
1 Front Med (Lausanne)
1 Front Neurol
1 Front Psychol
1 Genet Res (Camb)
1 Gut Microbes
1 HIV Med
1 J Clin Invest
2 J Gastrointestin Liver Dis
1 J Multidiscip Healthc
2 J Pediatr Gastroenterol Nutr
1 JGH Open
1 Metabolites
2 Prz Gastroenterol
1 Scand J Gastroenterol
2 United European Gastroenterol J
1 Virulence
1 World J Gastrointest Surg
1 World J Stem Cells


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Adv Exp Med Biol

  1. VASSALOS CM, Koutelekos I, Vassalou E
    Assessment of Prevalence of Dientamoeba fragilis and Its Associated Factors Compared to Those of Giardia lamblia and Blastocystis sp. Among Greek Patients with Suspicion of Intestinal Parasitosis.
    Adv Exp Med Biol. 2026;1490:181-189.
    PubMed         Abstract available


    Aliment Pharmacol Ther

  2. ALSAKARNEH S, Al Ta'ani O, Mahmoud MY, Syn WK, et al
    Comprehensive Risk Profile of Gastrointestinal and Extra Articular Comorbidities in Ehlers-Danlos Syndrome: A Propensity-Matched Analysis of 118,256 Individuals.
    Aliment Pharmacol Ther. 2025 Dec 23. doi: 10.1111/apt.70506.
    PubMed         Abstract available

  3. KHASAWNEH M, Goodoory VC, Ng CE, Ford AC, et al
    Stability of Classification Systems for Irritable Bowel Syndrome.
    Aliment Pharmacol Ther. 2025 Dec 25. doi: 10.1111/apt.70503.
    PubMed         Abstract available

  4. ZHENG NS, Bar N, Kuo B, Staller K, et al
    Research Communication: Healthcare Utilisation Patterns in Patients With Irritable Bowel Syndrome Across an Integrated Healthcare System.
    Aliment Pharmacol Ther. 2026;63:294-298.
    PubMed         Abstract available


    Ann Parasitol

  5. LEPCZYNSKA M
    The interplay between Blastocystis and human gut microbiota.
    Ann Parasitol. 2025;71:171-184.
    PubMed         Abstract available


    Best Pract Res Clin Gastroenterol

  6. VAN DEN HOUTE K
    Dietary approaches in functional bowel disorders.
    Best Pract Res Clin Gastroenterol. 2025;79:102077.
    PubMed         Abstract available

  7. BERSCHBACK M, Abber S, Smith J, Staller K, et al
    Avoidant/restrictive food intake disorder in disorders of gut-brain interaction.
    Best Pract Res Clin Gastroenterol. 2025;79:102078.
    PubMed         Abstract available

  8. BIESIEKIERSKI JR
    Clinical utility of gluten restriction in gastrointestinal disorders: Evidence, practice, and reappraisal of non-coeliac gluten sensitivity.
    Best Pract Res Clin Gastroenterol. 2025;79:102086.
    PubMed         Abstract available

  9. VON MUHLENBROCK C, Aronsohn F, Quera R, Madrid AM, et al
    The role of dietary fiber in the gastrointestinal tract: when, how and why?
    Best Pract Res Clin Gastroenterol. 2025;79:102080.
    PubMed         Abstract available


    Biomed Res Int

  10. AL-MADHAGI H
    A Systems Biology and Drug Repositioning Approach for the Analysis of Mutual Genes Between Celiac Disease and Irritable Bowel Syndrome.
    Biomed Res Int. 2025;2025:8227229.
    PubMed         Abstract available


    BMC Gastroenterol

  11. TACK C, Van den Houte K, Besard L, Capiau L, et al
    A study on the utility of inflammatory biomarkers in primary care irritable bowel syndrome: a sub analysis of the DOMINO randomized trial.
    BMC Gastroenterol. 2025 Dec 23. doi: 10.1186/s12876-025-04494.
    PubMed         Abstract available


    Clin Rheumatol

  12. ELKALLA MA, Ali YG, Ewais MM, Taha AS, et al
    Efficacy and safety of interventions for Fibromyalgia syndrome comorbid with Irritable bowel syndrome: systematic review.
    Clin Rheumatol. 2025 Dec 22. doi: 10.1007/s10067-025-07861.
    PubMed         Abstract available


    Cureus

  13. SAHU SK, Nath P, Mallick B, Praharaj D, et al
    Pharmacotherapy for Chronic Idiopathic Constipation and Constipation-Predominant Irritable Bowel Syndrome Beyond Conventional Laxatives: A Narrative Review.
    Cureus. 2025;17:e97523.
    PubMed         Abstract available

  14. CHAVHAN PKB, Sayeed MS, Saiyad SS, Shah MN, et al
    Lactose Intolerance in Irritable Bowel Syndrome: Prevalence, Subtype Correlations, and Clinical Predictors in an Indian Cohort.
    Cureus. 2025;17:e97697.
    PubMed         Abstract available


    Daru

  15. PUSHADAPU VVSK, Srikar G
    Development and evaluation of chitosan-xanthan gum-based controlled release nanoparticles of mebeverine hydrochloride for targeted IBS therapy: in silico, in vitro, and in vivo investigations.
    Daru. 2025;34:6.
    PubMed         Abstract available


    Eur J Gastroenterol Hepatol

  16. ANWAR DFF, Salma ZN, Oktaviani SD, Adiyatma FN, et al
    Effect of multistrain probiotics on symptom severity in irritable bowel syndrome: a systematic review and meta-analysis of irritable bowel syndrome-symptom severity score outcomes.
    Eur J Gastroenterol Hepatol. 2025 Dec 24. doi: 10.1097/MEG.0000000000003074.
    PubMed         Abstract available


    Front Med (Lausanne)

  17. BALLENA-CAICEDO J, Zuzunaga-Montoya FE, Valladolid-Sandoval LAM, Valladares-Garrido MJ, et al
    Prevalence of irritable bowel syndrome in medical students: a systematic review and meta-analysis.
    Front Med (Lausanne). 2025;12:1714085.
    PubMed         Abstract available


    Front Neurol

  18. WU W, Qiu Y, Liang F, Lu W, et al
    Acupuncture and moxibustion in irritable bowel syndrome: a mechanistic exploration from heart rate variability to cardiac metabolism.
    Front Neurol. 2025;16:1716708.
    PubMed         Abstract available


    Front Psychol

  19. PROSPERO L, Riezzo G, Laselva G, D'Attoma B, et al
    Somatization, psychological distress, and quality of life across fibromyalgia, irritable bowel syndrome, and their comorbid phenotype: a cross-sectional clinical comparison.
    Front Psychol. 2025;16:1709017.
    PubMed         Abstract available


    Genet Res (Camb)

  20. SUN F, Li H, Gong B, Hui S, et al
    Investigating the Causal Relationship and Shared Genetic Basis Between Major Depression Disorder and Eight Types of Gastrointestinal Diseases.
    Genet Res (Camb). 2025;2025:6931243.
    PubMed         Abstract available


    Gut Microbes

  21. DOWRICK JM, Roy NC, Carco C, James SC, et al
    Integrated multi-omic and symptom clustering reveals lower-gastrointestinal disorders of gut-brain interaction heterogeneity.
    Gut Microbes. 2026;18:2604871.
    PubMed         Abstract available


    HIV Med

  22. PORCHIA DD, Wang Y, Zhou Z, Chen M, et al
    Cannabis use, microbial diversity and Dialister abundance in older adults with HIV: A cross-sectional study.
    HIV Med. 2025 Dec 22. doi: 10.1111/hiv.70180.
    PubMed         Abstract available


    J Clin Invest

  23. LORSCH ZS, Liddle RA
    Mechanisms and clinical implications of gut-brain interactions.
    J Clin Invest. 2026;136:e196346.
    PubMed         Abstract available


    J Gastrointestin Liver Dis

  24. MOU JJ, Xu L, Luo YF, Tao QF, et al
    Assessing the Efficacy and Safety of Multiple Drugs for IBS-C: A Systematic Review and Network Meta-Analysis.
    J Gastrointestin Liver Dis. 2025;34:503-509.
    PubMed         Abstract available

  25. POPA IV, Dranga M, Nedelciuc O, Mihai C, et al
    Artificial Intelligence Methods for the Differential Diagnosis of Irritable Bowel Syndrome and Inflammatory Bowel Disease: A Systematic Review.
    J Gastrointestin Liver Dis. 2025;34:510-514.
    PubMed         Abstract available


    J Multidiscip Healthc

  26. DU Y, Xu H, Xiong J, Wang Z, et al
    Tracing Evolution of Hotspots and Frontiers: A Bibliometric Exploration of Acupuncture Therapy in Irritable Bowel Syndrome.
    J Multidiscip Healthc. 2025;18:8133-8152.
    PubMed         Abstract available


    J Pediatr Gastroenterol Nutr

  27. CRISTOFORI F, Calabrese FM, De Angelis M, Francavilla R, et al
    Data over doubt: Clarifications on calcium butyrate efficacy in pediatric irritable bowel syndrome.
    J Pediatr Gastroenterol Nutr. 2025 Dec 30. doi: 10.1002/jpn3.70326.
    PubMed        

  28. VERMEIJDEN NK, Gordon M, Benninga M, Vlieger A, et al
    Analysis of "Calcium butyrate efficacy in pediatric irritable bowel syndrome".
    J Pediatr Gastroenterol Nutr. 2025 Dec 30. doi: 10.1002/jpn3.70328.
    PubMed        


    JGH Open

  29. CHIU YT, Lee FJ, Kuo CY, Yang PC, et al
    The Post-Cholecystectomy Gut Microbiota Follows a Time-Varying Change-A Pilot Study.
    JGH Open. 2025;9:e70329.
    PubMed         Abstract available


    Metabolites

  30. CAI E, Kouznetsova VL, Tsigelny IF
    Metabolomics-Based Machine Learning Diagnostics of Post-Acute Sequelae of SARS-CoV-2 Infection.
    Metabolites. 2025;15:801.
    PubMed         Abstract available


    Prz Gastroenterol

  31. SINGH A, Singh R
    The gastrointestinal endothelin system: receptors, cellular actions, and involvement in gastrointestinal disorders.
    Prz Gastroenterol. 2025;20:372-381.
    PubMed         Abstract available

  32. SZURA E, Poniewierka E
    Impact of physical activity and selected relaxation techniques on the quality of life of female patients with irritable bowel syndrome.
    Prz Gastroenterol. 2025;20:439-442.
    PubMed         Abstract available


    Scand J Gastroenterol

  33. HAMBERG LEVEDAHL K, Carlson M, Nilsson GP, Jakobsson Larsson B, et al
    Investigating instruments for evaluation of gastrointestinal burdens in patients with systemic mastocytosis: an exploratory multimethod study.
    Scand J Gastroenterol. 2025 Dec 21:1-10. doi: 10.1080/00365521.2025.2604778.
    PubMed         Abstract available


    United European Gastroenterol J

  34. MIDENFJORD I, Khadija M, Sundelin E, Trindade IA, et al
    Increased Disease Burden in Irritable Bowel Syndrome With Comorbid Conditions and Psychiatric Diagnoses in a Multinational European Cohort: Results From the DISCOvERIE Project.
    United European Gastroenterol J. 2026;14:e70157.
    PubMed         Abstract available

  35. GUAGNOZZI D, Gonzalez-Castro AM, Zabana Y, Fernandez-Banares F, et al
    Integrated Multi-Omic Analysis Identifies Altered Colonic Brush Border Profile as a Key Feature of Microscopic Colitis.
    United European Gastroenterol J. 2026;14:e70156.
    PubMed         Abstract available


    Virulence

  36. HSU LH, Chou YP, Shen TL, Wieczorek D, et al
    Otilonium bromide exhibits novel antifungal activity against Candida albicans via regulating iron homeostasis.
    Virulence. 2026;17:2609407.
    PubMed         Abstract available


    World J Gastrointest Surg

  37. SHANG S, Liu Y, Bai QL, Zhang Z, et al
    Latent myofascial trigger point injection improves symptoms in functional gastrointestinal disorders.
    World J Gastrointest Surg. 2025;17:111359.
    PubMed         Abstract available


    World J Stem Cells

  38. ZHANG HM, Zhang Y, Luo GJ, Zhang AX, et al
    Human umbilical cord mesenchymal stem cells alleviated diarrhea-type irritable bowel syndrome by improving intestinal function.
    World J Stem Cells. 2025;17:112100.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Irritable Bowel Syndrome is free of charge.